Atricure CryoICE Cryogenic Probe Recalled for Potential Sterility Compromise
Atricure Inc is recalling 19,190 CryoICE cryogenic probes due to packaging defects that may have compromised sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a sterile medical device where the hazard is a potential loss of sterility (risk of infection). As no specific injuries or illnesses are reported in the source text, this fits the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Atricure Inc is recalling 19,190 units of the CryoICE cryogenic probe for cardiac ablation surgery. The recall is due to packaging defects that may have compromised the sterility of the devices. The CryoICE probe is a sterile, single-use device intended for the cryosurgical treatment of cardiac arrhythmias.
The recall was initiated because mishandling of the product during the packaging process could have inadvertently damaged the sterile barrier. The affected product was distributed worldwide, including in the United States, Canada, and numerous other countries, as well as to 17 government consignees.
Healthcare providers and consumers should check their inventory for the specific batch numbers listed in the official recall notice. If the product is found, it should be stopped from use and returned to Atricure Inc or the distributor for credit or replacement.
The recalled product
- Product
- Cryogenic probe for cardiac ablation surgery, packaged individually in Tyvek pouches Product Usage: Cryogenic probe for cardiac ablation surgery. The CryoICE cryoablation probe is a sterile, single use device intended to use in the cryosurgical treatment of cardiac arrhythmia
- Manufacturer
- Atricure Inc
- Affected units
- 19,190
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Atricure Inc
See all →- HighTank hose assembly recalled for incorrect material and missing perforations
FDA (Devices) · 2024-02-07
- HighCryo Module Tank Hose Assemblies Recalled for Material and Design Defects
FDA (Devices) · 2024-02-07
- HighAtriCure EPi-Sense Guided Coagulation System Recalled for Compromised Sterile Seal
FDA (Devices) · 2019-07-03
- HighAtriCure Recalls COBRA FUSION 50 Ablation Systems Due to Thromboembolism Risk
FDA (Devices) · 2019-02-20
- SevereAtriCure COBRA FUSION 150 Ablation System Recalled for Thromboembolism Risk
FDA (Devices) · 2019-02-20
Same hazard · sterility compromise
See all →- SevereSpectra Medical Devices Recalls Sodium Chloride Injection Ampules Due to Sterility Concerns
FDA (Devices) · 2026-08-19
- HighIntramedullary Bone Saw Blade Assembly Recalled Due to Potential Sterile Barrier Damage
FDA (Devices) · 2026-08-12
- ModerateIntramedullary Bone Saw Blade Assembly Recalled Due to Potential Sterile Barrier Damage
FDA (Devices) · 2026-08-12
- HighIntramedullary Bone Saw Blade Assemblies Recalled Due to Potential Packaging Damage
FDA (Devices) · 2026-08-12
- HighStryker Recalls Ahto Dual Spike Tube Set Due to Leaking Handpiece
FDA (Devices) · 2026-08-12